Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Connell

Showing results (321-330 of 350) with videos related to

Pageof 35
Sort By:
Arthritis and Rheumatism|October 19, 2011
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate aloneJoel M Kremer, Stanley Cohen, Bethanie E Wilkinson, et al.
Implementation Science : IS|November 4, 2021
The effectiveness of quality improvement collaboratives in improving stroke care and the facilitators and barriers to their implementation: a systematic reviewHayley J Lowther, Joanna Harrison, James E Hill, et al.
BMC Women'S Health|February 5, 2026
Evidence of compensatory elastin remodeling in non-prolapsed uterosacral ligaments and its divergence in histopathological subtypes of pelvic organ prolapseDavid J Orlicky, E Erin Smith, Aidan Kuhn, et al.
RMD Open|April 12, 2024
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety studyMaya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, et al.
The New England Journal of Medicine|January 26, 2022
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisSteven R Ytterberg, Deepak L Bhatt, Ted R Mikuls, et al.
Diseases of the Colon and Rectum|December 6, 2019
Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital ReconstructionLiliana G Bordeianou, Jennifer T Anger, Marylise Boutros, et al.
Female Pelvic Medicine & Reconstructive Surgery|December 14, 2019
Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital ReconstructionLiliana G Bordeianou, Jennifer T Anger, Marylise Boutros, et al.
Implementation Science Communications|January 8, 2026
Exploring factors influencing implementation across the explanatory-to-pragmatic trial continuum: a sequential qualitative integration of delivering higher-intensity walking exercise within inpatient stroke rehabilitationSuzanne Ackerley, Stanley H Hung, Lisa Sheehy, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan studyVibeke Strand, Désirée van der Heijde, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 23, 2019
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III StudyDésirée van der Heijde, Vibeke Strand, Yoshiya Tanaka, et al.
Pageof 35

Showing results (321-330 of 350) with videos related to

Sort By:
Pageof 35
Arthritis and Rheumatism|October 19, 2011
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate aloneJoel M Kremer, Stanley Cohen, Bethanie E Wilkinson, et al.
Implementation Science : IS|November 4, 2021
The effectiveness of quality improvement collaboratives in improving stroke care and the facilitators and barriers to their implementation: a systematic reviewHayley J Lowther, Joanna Harrison, James E Hill, et al.
BMC Women'S Health|February 5, 2026
Evidence of compensatory elastin remodeling in non-prolapsed uterosacral ligaments and its divergence in histopathological subtypes of pelvic organ prolapseDavid J Orlicky, E Erin Smith, Aidan Kuhn, et al.
RMD Open|April 12, 2024
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety studyMaya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, et al.
The New England Journal of Medicine|January 26, 2022
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid ArthritisSteven R Ytterberg, Deepak L Bhatt, Ted R Mikuls, et al.
Diseases of the Colon and Rectum|December 6, 2019
Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital ReconstructionLiliana G Bordeianou, Jennifer T Anger, Marylise Boutros, et al.
Female Pelvic Medicine & Reconstructive Surgery|December 14, 2019
Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital ReconstructionLiliana G Bordeianou, Jennifer T Anger, Marylise Boutros, et al.
Implementation Science Communications|January 8, 2026
Exploring factors influencing implementation across the explanatory-to-pragmatic trial continuum: a sequential qualitative integration of delivering higher-intensity walking exercise within inpatient stroke rehabilitationSuzanne Ackerley, Stanley H Hung, Lisa Sheehy, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan studyVibeke Strand, Désirée van der Heijde, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 23, 2019
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III StudyDésirée van der Heijde, Vibeke Strand, Yoshiya Tanaka, et al.
Pageof 35